3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide

C19H20ClF4N5O2 — CID 118061457

IUPAC3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide
SMILESCC(C)(C)NC(=O)c1c(-c2ccc(F)c(Cl)c2)nn2c1CN(C(N)=O)C(C(F)(F)F)C2
InChIInChI=1S/C19H20ClF4N5O2/c1-18(2,3)26-16(30)14-12-7-28(17(25)31)13(19(22,23)24)8-29(12)27-15(14)9-4-5-11(21)10(20)6-9/h4-6,13H,7-8H2,1-3H3,(H2,25,31)(H,26,30)
InChIKeyWBYQCPJVVMPGSJ-UHFFFAOYSA-N
MW461.85 g/mol
LogP3.70
Rot. Bonds2

About 3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide

3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide (PubChem CID 118061457) has the molecular formula C19H20ClF4N5O2 and a molecular weight of 461.85 g/mol. Its IUPAC name is 3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide.

Molecular Properties

Compound Name3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide
PubChem CID118061457
Molecular FormulaC19H20ClF4N5O2
Molecular Weight461.85 g/mol
Exact Mass461.12
IUPAC Name3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide
SMILESCC(C)(C)NC(=O)c1c(-c2ccc(F)c(Cl)c2)nn2c1CN(C(N)=O)C(C(F)(F)F)C2
InChIInChI=1S/C19H20ClF4N5O2/c1-18(2,3)26-16(30)14-12-7-28(17(25)31)13(19(22,23)24)8-29(12)27-15(14)9-4-5-11(21)10(20)6-9/h4-6,13H,7-8H2,1-3H3,(H2,25,31)(H,26,30)
InChIKeyWBYQCPJVVMPGSJ-UHFFFAOYSA-N
XLogP3.70
TPSA93.25 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds2
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500461.85
LogP ≤ 53.70
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze 3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide?
The IUPAC name of 3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide (CID 118061457) is 3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide.
What is the SMILES notation for 3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide?
The canonical SMILES for 3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide is CC(C)(C)NC(=O)c1c(-c2ccc(F)c(Cl)c2)nn2c1CN(C(N)=O)C(C(F)(F)F)C2.
What is the InChIKey of 3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide?
The InChIKey is WBYQCPJVVMPGSJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H20ClF4N5O2/c1-18(2,3)26-16(30)14-12-7-28(17(25)31)13(19(22,23)24)8-29(12)27-15(14)9-4-5-11(21)10(20)6-9/h4-6,13H,7-8H2,1-3H3,(H2,25,31)(H,26,30).
What are the key properties of 3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide?
3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide has a molecular weight of 461.85 g/mol, XLogP of 3.70, 2 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 3-N-tert-butyl-2-(3-chloro-4-fluorophenyl)-6-(trifluoromethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-3,5-dicarboxamide is sourced from PubChem (CID 118061457), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).